Literature DB >> 23044098

A comparative study of the anticoagulant activities of eleven fucoidans.

Weihua Jin1, Quanbin Zhang, Jing Wang, Wenjing Zhang.   

Abstract

Seven fucoidans that differed only with respect to the average molecular weight and four fucoidans that differed with respect to both the molar ratio of fucose to galactose and the average molecular weight were obtained. The anticoagulant activities of these fucoidans were determined in order to understand the effects of the average molecular weight and the content of galactose. Fucoidans Y5-Y11, with the average molecular weight in the range of 50.1-8.4 kDa, showed decreasing activity at three concentrations and dose-dependent activity in the APTT and TT assays. Y1-Y4, which differed with respect to the average molecular weight and the molar ratio of fucose to galactose, exhibited complicated results in the APTT and TT assays. It was shown that not only the average molecular weight but also the molar ratio of fucose to galactose affected the anticoagulant activity of fucoidans.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044098     DOI: 10.1016/j.carbpol.2012.07.067

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  18 in total

1.  The Endo-α(1,3)-Fucoidanase Mef2 Releases Uniquely Branched Oligosaccharides from Saccharina latissima Fucoidans.

Authors:  Vy Ha Nguyen Tran; Thuan Thi Nguyen; Sebastian Meier; Jesper Holck; Hang Thi Thuy Cao; Tran Thi Thanh Van; Anne S Meyer; Maria Dalgaard Mikkelsen
Journal:  Mar Drugs       Date:  2022-04-29       Impact factor: 6.085

2.  Sulfated Polysaccharides Isolated from Cloned Grateloupia filicina and Their Anticoagulant Activity.

Authors:  Xiaolin Chen; Shengfeng Yang; Jinxia Wang; Lin Song; Ronge Xing; Song Liu; Huahua Yu; Pengcheng Li
Journal:  Biomed Res Int       Date:  2015-04-07       Impact factor: 3.411

3.  The Structure-Activity Relationship between Marine Algae Polysaccharides and Anti-Complement Activity.

Authors:  Weihua Jin; Wenjing Zhang; Hongze Liang; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-12-25       Impact factor: 5.118

4.  Degradation of Sargassum crassifolium Fucoidan by Ascorbic Acid and Hydrogen Peroxide, and Compositional, Structural, and In Vitro Anti-Lung Cancer Analyses of the Degradation Products.

Authors:  Tien-Chiu Wu; Yong-Han Hong; Yung-Hsiang Tsai; Shu-Ling Hsieh; Ren-Han Huang; Chia-Hung Kuo; Chun-Yung Huang
Journal:  Mar Drugs       Date:  2020-06-26       Impact factor: 5.118

5.  Fucoidans inhibit the formation of post-operative abdominal adhesions in a rat model.

Authors:  Alex J Charboneau; John P Delaney; Greg Beilman
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

Review 6.  Therapeutic Effects of Fucoidan: A Review on Recent Studies.

Authors:  Sibusiso Luthuli; Siya Wu; Yang Cheng; Xiaoli Zheng; Mingjiang Wu; Haibin Tong
Journal:  Mar Drugs       Date:  2019-08-21       Impact factor: 5.118

7.  The Pharmacokinetics of Fucoidan after Topical Application to Rats.

Authors:  Olga N Pozharitskaya; Alexander N Shikov; Ekaterina D Obluchinskaya; Heikki Vuorela
Journal:  Mar Drugs       Date:  2019-12-06       Impact factor: 5.118

Review 8.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

9.  A New Route of Fucoidan Immobilization on Low Density Polyethylene and Its Blood Compatibility and Anticoagulation Activity.

Authors:  Kadir Ozaltin; Marián Lehocký; Petr Humpolíček; Jana Pelková; Petr Sáha
Journal:  Int J Mol Sci       Date:  2016-06-09       Impact factor: 5.923

10.  Investigation of Different Molecular Weight Fucoidan Fractions Derived from New Zealand Undaria pinnatifida in Combination with GroA Therapy in Prostate Cancer Cell Lines.

Authors:  Xu Yang; Sheng Wang; Sari Schokoroy Trangle; Yan Li; William Lindsey White; Jinyao Li; Tianlei Ying; Qingjun Kong; Yu Zhao; Jun Lu
Journal:  Mar Drugs       Date:  2018-11-18       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.